Business Description
J-Pharma Co Ltd
ISIN : JP3387030004
Description
J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. It is focused on a single segment of the drug discovery business, focusing on R&D and clinical development. The company's two compounds in clinical development are Nanbran Latte (JPH203) and JPH034.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.79 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | N/A/9 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 41.4 | |||||
9-Day RSI | 34.56 | |||||
14-Day RSI | 31.12 | |||||
3-1 Month Momentum % | -43.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.88 | |||||
Quick Ratio | 4.88 | |||||
Cash Ratio | 3.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -18.97 | |||||
ROA % | -15.42 | |||||
ROIC % | -118.2 | |||||
ROC (Joel Greenblatt) % | -568.15 | |||||
ROCE % | -20.38 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 2.21 | |||||
Price-to-Tangible-Book | 2.21 | |||||
EV-to-EBIT | -5.86 | |||||
EV-to-EBITDA | -5.86 | |||||
EV-to-FCF | -1.75 | |||||
| Price-to-Net-Current-Asset-Value | 2.21 | |||||
| Price-to-Net-Cash | 2.93 | |||||
Earnings Yield (Greenblatt) % | -17.06 | |||||
FCF Yield % | -32.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
J-Pharma Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | |||
| EPS (TTM) (円) | -25.123 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 31.12 | ||
| 14-Day ATR (円) | 19.936278 | ||
| 20-Day SMA (円) | 321.05 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (円) | 271 - 809 | ||
| Shares Outstanding (Mil) | 17.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
J-Pharma Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
J-Pharma Co Ltd Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
J-Pharma Co Ltd Frequently Asked Questions
What is J-Pharma Co Ltd(TSE:520A)'s stock price today?
The current price of TSE:520A is 円290.00. The 52 week high of TSE:520A is 円809.00 and 52 week low is 円271.00.
When is next earnings date of J-Pharma Co Ltd(TSE:520A)?
The next earnings date of J-Pharma Co Ltd(TSE:520A) is .
Does J-Pharma Co Ltd(TSE:520A) pay dividends? If so, how much?
J-Pharma Co Ltd(TSE:520A) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on J-Pharma Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers